NGAVNext-Generation Anthrax Vaccine
References in periodicals archive ?
The NGAV grant provides important funding, over a five-year period, for animal model development and cGMP manufacturing of clinical lots of alternative formulations of a next generation anthrax vaccine, which may then be tested in a subsequent clinical trial.
We are very pleased that the NIAID, with these grants, has elected to support the continued development of both our rBOT and NGAV candidates," said Daniel J.
There are a number of important factors that could cause the company's actual results to differ materially from those indicated by such forward-looking statements, including the timing of, and the potential for successful outcomes resulting from future product development efforts related to rBOT Vaccine Candidate and NGAV Candidate; and our ability to obtain additional funding from the U.